R. Don Elsey
Overview
R. Don Elsey received an average of $776K in total compensation, including $281K in salary, at Lyra Therapeutics from 2019 to 2021. R Elsey also received an average of $931K at Senseonics Holdings from 2015 to 2018 and an average of $637K at Emergent BioSolutions from 2006 to 2012.
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2012
- 2011
- 2010
Lyra TherapeuticsFormer Chief Financial Officer
Lyra TherapeuticsChief Financial Officer
Lyra TherapeuticsChief Financial Officer
Senseonics HoldingsFormer Chief Financial Officer
Senseonics HoldingsChief Financial Officer
Senseonics HoldingsChief Financial Officer
Senseonics HoldingsChief Financial Officer
Emergent BioSolutionsFormer Senior Vice President, Finance and Administration, Chief Financial Officer
Emergent BioSolutionsFormer Senior Vice President, Finance and Administration, Chief Financial Officer
Emergent BioSolutionsFormer Senior Vice President, Finance and Administration, Chief Financial Officer
Source: SEC filings on April 27, 2022, April 14, 2021, April 18, 2019, April 25, 2018, April 17, 2017, April 8, 2013, April 6, 2012, April 7, 2011, and April 15, 2008.
Related executives
We found 25 more executives who work or worked at Lyra Therapeutics, Senseonics Holdings, andEmergent BioSolutions.
Harlan Waksal
Lyra Therapeutics
Chairman
Timothy Goodnow
Senseonics Holdings
Chief Executive Officer
Maria Palasis
Lyra Therapeutics
Chief Executive Officer
Mukul Jain
Senseonics Holdings
Chief Operating Officer
Richard Nieman
Lyra Therapeutics
Chief Medical Officer
Kenneth Horton
Senseonics Holdings
General Counsel
Robert Kramer
Emergent BioSolutions
Chief Executive Officer
Fuad El-Hibri
Emergent BioSolutions